YU30495A - Postupak za dobijanje hbv površinskih proteina - Google Patents

Postupak za dobijanje hbv površinskih proteina

Info

Publication number
YU30495A
YU30495A YU30495A YU30495A YU30495A YU 30495 A YU30495 A YU 30495A YU 30495 A YU30495 A YU 30495A YU 30495 A YU30495 A YU 30495A YU 30495 A YU30495 A YU 30495A
Authority
YU
Yugoslavia
Prior art keywords
hbv
surface proteins
yeast strains
procedure
particles
Prior art date
Application number
YU30495A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
H. Markus
L. Schultz
A.R. Shaw
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of YU30495A publication Critical patent/YU30495A/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00Reverse transcribing DNA viruses
    • C12N2730/00011Details
    • C12N2730/10011Hepadnaviridae
    • C12N2730/10111Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
YU30495A 1994-05-16 1995-05-12 Postupak za dobijanje hbv površinskih proteina YU30495A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24280094A 1994-05-16 1994-05-16

Publications (1)

Publication Number Publication Date
YU30495A true YU30495A (sh) 1997-12-05

Family

ID=22916238

Family Applications (1)

Application Number Title Priority Date Filing Date
YU30495A YU30495A (sh) 1994-05-16 1995-05-12 Postupak za dobijanje hbv površinskih proteina

Country Status (4)

Country Link
AU (1) AU2515095A (fr)
HR (1) HRP950289A2 (fr)
WO (1) WO1995031558A1 (fr)
YU (1) YU30495A (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104628830A (zh) * 2015-01-23 2015-05-20 深圳康泰生物制品股份有限公司 重组酿酒酵母表达HBsAg的制备工艺及其分离纯化工艺、HBsAg和乙肝疫苗

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135854A (en) * 1987-10-29 1992-08-04 Zymogenetics, Inc. Methods of regulating protein glycosylation
CA2067003A1 (fr) * 1991-04-29 1992-10-30 Peter J. Kniskern Vaccin mutant de variante d'antigene de surface d'hbv
IL101651A0 (en) * 1991-04-29 1992-12-30 Merck & Co Inc Hepatitis b virus surface proteins with reduced host carbohydrate content

Also Published As

Publication number Publication date
HRP950289A2 (en) 1997-04-30
WO1995031558A1 (fr) 1995-11-23
AU2515095A (en) 1995-12-05

Similar Documents

Publication Publication Date Title
Lenoir et al. Fish rhabdoviruses: comparative study of protein structure
DE69535018D1 (de) Papillomavirus vakzine
LU91391I2 (fr) "La combinaison de particules viroïdes de la protéine L1 recombinante du papillomavirus humain de types 16 et 18" Cervarix
ATE326479T1 (de) Varianten von antigenen des menschlichen papillomvirus
NL300324I1 (nl) Op papillomavirus lijkende deeltjes, fusie-eiwitten alsook werkwijze
ATE234108T1 (de) Therapeutikum zur unterdrückung von schnarchgeräuschen
DK0623169T3 (da) Hepatitis E virus og fremgangsmåde
BR9510520A (pt) Proteína de capsídeo de vírus papiloma isolada e purificada capsídeos partículas semelhantes a vírus processo de produzir a proteína purificada proteína do vírus papilona recombinante vacina composições farmacêuticas processo de tratamento ou de prevenção contra a infecção por vírus papilona kit para a detecção de vírus papiloma ou de anticorpos a vírus papiloma processos para a produção de uma proteína de capsídeo de vírus papilona recombinante para induzir uma resposta imunológica em um animalvertebrado sistema sintetico processos de obtenção de partículas semelhantes a vírus de obtenção da capsideos prificados capsideos de virus papilona
DE69933875D1 (de) Protein-verabreichungssystem, das dem menschlichen papillomavirus ähnliche partikel benützt.
YU30495A (sh) Postupak za dobijanje hbv površinskih proteina
EP1438066A4 (fr) Compositions immunogenes de cellules entieres de bacteries rendues incapables
YU23993A (sh) Preparati za tretiranje infekcija i oboljenja izazvanih virusom hepatitisa b
YU45292A (sh) Različiti površinski proteini hepatitis b virusa koji obrazuju čestice
TW200509964A (en) VP1 of foot-and-mouth disease virus
ATE360061T1 (de) Replikationsmangelhafte mutanten von herpesvirus
PT871738E (pt) Particulas virais recombinantes e aplicacoes vacinais e antitumorais
NO933897L (no) HBV-overflateproteiner med redusert vertskarbohydrat
DK257887D0 (da) Fremgangsmaade til fremstilling af hbcag i gaer og plasmid til brug ved udoevelse af fremgangsmaaden
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
RU93058279A (ru) Система экспрессии, белок, вакцина, реагент
PT592574E (pt) Processo de producao de proteinas recombinantes e celulas hospedeiras utilizadas